Integrated Diagnostics Holdings PLC
LSE:IDHC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.2845
0.535
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Integrated Diagnostics Holdings PLC
Wall Street
Price Targets
IDHC Price Targets Summary
Integrated Diagnostics Holdings PLC
According to Wall Street analysts, the average 1-year price target for
IDHC
is 0.545 USD
with a low forecast of 0.455 USD and a high forecast of 0.714 USD.
Price Targets
Revenue
Forecast
Revenue Estimate
Integrated Diagnostics Holdings PLC
For the last 8 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's revenue is
19%.
The projected
CAGR
for the next 4 years is
25%.
Operating Income
Forecast
Operating Income Estimate
Integrated Diagnostics Holdings PLC
For the last 8 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's operating income is
14%.
The projected
CAGR
for the next 3 years is
40%.
Net Income
Forecast
Net Income Estimate
Integrated Diagnostics Holdings PLC
For the last 8 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's net income is
17%.
The projected
CAGR
for the next 3 years is
39%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IDHC's stock price target?
Price Target
0.545
USD
According to Wall Street analysts, the average 1-year price target for
IDHC
is 0.545 USD
with a low forecast of 0.455 USD and a high forecast of 0.714 USD.
What is Integrated Diagnostics Holdings PLC's Revenue forecast?
Projected CAGR
25%
For the last 8 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's revenue is
19%.
The projected
CAGR
for the next 4 years is
25%.
What is Integrated Diagnostics Holdings PLC's Operating Income forecast?
Projected CAGR
40%
For the last 8 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's operating income is
14%.
The projected
CAGR
for the next 3 years is
40%.
What is Integrated Diagnostics Holdings PLC's Net Income forecast?
Projected CAGR
39%
For the last 8 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's net income is
17%.
The projected
CAGR
for the next 3 years is
39%.
You don't have any saved screeners yet
